title: Citalopram for social phobia: a clinical case series.
abstract: Social anxiety disorder is a common illness with significant associated disability. Serotonin selective reuptake inhibitors (SSRIs) have become first-line treatment given their improved tolerability; however, there are few reports on the use of citalopram. Nine consecutive patients with a primary diagnosis of DSM-IV generalized social phobia were prospectively treated with citalopram. Citalopram was generally well-tolerated, and seven patients achieved responder status. This series of patients improved significantly on all measures. Results suggest that citalopram may be a safe and effective treatment for social anxiety disorder.
authors.affiliation: Anxiety Disorders Program, Massachusetts General Hospital, Boston 02114, USA. nsimon@partners.org
authors.forename: N M
authors.initials: NM
authors.lastname: Simon
authors.forename: S G
authors.initials: SG
authors.lastname: Sharma
authors.forename: J J
authors.initials: JJ
authors.lastname: Worthington
authors.forename: P C
authors.initials: PC
authors.lastname: Marzol
authors.forename: M H
authors.initials: MH
authors.lastname: Pollack
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D015283:Citalopram / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010698:Phobic Disorders / Q000188:drug therapy* / Q000523:psychology; D011446:Prospective Studies
chemical_list: D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram